Danna nan don nuna banners ɗin ku akan wannan shafin kuma ku biya kawai don nasara

Labaran Waya

Ciwon Hankali Yana Karuwa

Written by edita

A cewar wani rahoto daga Grand View Research "Babban buƙatun likita da ba a cika su ba da kuma shirye-shiryen gwamnati don rage cututtukan hauka da cututtukan jijiyoyin jiki suna haifar da kasuwa don tsarin jiyya na tsakiya (CNS).

A cewar WHO, tattalin arzikin duniya yana yin asara saboda bakin ciki kuma damuwa ya haura dalar Amurka tiriliyan 1 a kowace shekara kuma ana sa ran karuwar tushen lafiyar kwakwalwa a duniya zai kara hasarar tattalin arzikin da dala tiriliyan 16 a shekarar 2030. kuma manyan 'yan wasa suna ɗaukar dabarun talla daban-daban kamar sabbin haɓaka samfura, haɗin gwiwa, haɓaka yanki, haɗaka da saye, da sabon amincewar samfur, don ƙarfafa matsayinsu." Rahoton ya yi hasashen cewa girman kasuwar tsarin jijiya na duniya ana sa ran zai kai dala biliyan 205.0 nan da shekarar 2028 kuma ana sa ran zai fadada a CAGR na 7.4% zuwa 2028. 

Rahoton ya ci gaba da cewa: “Kasancewar samfuran bututun mai daga manyan kamfanonin harhada magunguna… da sauransu ana sa ran za su haɓaka ci gaban kasuwa a cikin lokacin hasashen. Bayan haka, sauran kamfanonin harhada magunguna suma suna da hannu sosai a cikin haɓaka sabbin hanyoyin kwantar da hankali da kuma saka hannun jari sosai don haɓaka ingantattun hanyoyin warkewa don maganin cututtukan da ke da alaƙa da CNS. Ayyukan Biotechs a kasuwanni a yau sun haɗa da: Pasithea Therapeutics Corp., Alkermes plc, Passage Bio, Inc., Acadia Healthcare Company, Inc., da kuma Life Sciences.

Yawancin magungunan ci gaba na ƙarshen zamani don maganin cututtukan neurodegenerative irin su cutar Alzheimer, Multi sclerosis, Parkinson's disease, da kuma amyotrophic lateral sclerosis ... wasu magungunan da za a iya sayar da su a cikin shekaru biyar zuwa takwas masu zuwa don maganin ciwon daji. daban-daban nuni na neurodegenerative cuta. Baya ga cututtukan neurodegenerative, migraine, schizophrenia, da farfadiya sune manyan alamun cutar CNS waɗanda ke da yuwuwar ƴan takarar magunguna a cikin bututun. Kamfanonin harhada magunguna suna amfani da dabaru kamar haɓaka samfura, haɗaka da saye, da haɗin gwiwa don ƙarfafa matsayinsu a kasuwa."

Shafin Farko

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Leave a Comment

2 Comments

  • Sanarwa Jama'a>>>Maganin da aka dade ana jira na HERPES, HIV, HPV, HSV1&2, CIWON SUGA, CANCER, CIWON FARji ya kare. Dokta Osato ya zo ne domin ya ceci dan Adam da maganinsa na ganye kuma ana ba shi shawarar a duk fadin duniya don kyakkyawan aikin da yake yi a rayuwar mutane ta hanyar magance su daga cututtuka / ƙwayoyin cuta daban-daban. Ya kuma warkar da ni daga al'aura Herpes da maganin ganye. Idan kuna buƙatar maganin, tuntuɓi Dr Osato akan imel ɗin sa: [email kariya] ko WhatsApp shi a +2347051705853. Kar ki mutu kiyi shiru kina tunanin babu maganin ciwon 1&2. Tuntuɓi Dr Osato a yau kuma ku kawar da wannan mummunar cuta / ƙwayar cuta a jikin ku. Gidan yanar gizon sa shine osatoherbalcure.wordpress.com

  • Tare da ciwon ƙwayar cuta na amyotrophic lateral sclerosis (ALS), abu na farko da ya faru kusan shekaru 2 da suka wuce yanzu, yana magana kamar na bugu. ban kasance ba. Da farko na inganta magana (fadi a sarari amma a hankali) amma yanzu ba zan iya yin magana ta hanyar da aka yarda da ita ba. Bayan shekara guda cin abinci ya zama matsala, ina cizon harshe da lebena, tauna ta zama mai rauni kuma ta kasa sarrafa ta. Ba da jimawa ba sai wasu yatsu suka fara faɗuwa da ni sai abubuwa su fita daga hannuna. Wani wuri a lokacin an gano bulbar ALS. Rilutek (riluzole) yayi kadan don taimaka min. Kungiyar likitocin ta yi ma kasa da haka. Ragewara ta yi sauri kuma tana da ban tsoro.. Mun gwada kowane harbi da aka samu amma babu abin da ke aiki. An sami ɗan ci gaba idan aka sami ingantaccen magani, mai ba da kulawar mu ya gabatar da mu zuwa asibitin Kiwon Lafiya na Kycuyu ALS/MND maganin ganye. Maganin abin al'ajabi ne. Na warke sosai! Ziyarci www. kycuyuhealthclinic. ku m

Share zuwa...